Leuven Pharma Services: what changed
Leuven Pharma Services
Largest movements
- Tangible fixed assets +€30,603
up €30,603 (+2,080%), from €1,471 to €32,074
- Other debts +€362,955
up €362,955 (+53.6%), from €677,346 to €1.0m
- Reserves -€332,763
down €332,763 (-50.9%), from €653,718 to €320,955
- Debts after one year -€97,162
down €97,162 (-17.1%), from €567,903 to €470,741
- Tax, wage and social debts +€40,048
up €40,048 (+193%), from €20,761 to €60,809
of which Taxes: +€36,757
- Accrued charges and deferred income +€27,164
up €27,164 (+436%), from €6,226 to €33,390
- Gross operating margin -€77,519
down €77,519 (-28.9%), from €268,154 to €190,635
- Taxes -€24,928
down €24,928 (-99.2%), from €25,123 to €195
- Financial charges +€24,847
up €24,847 (+165%), from €15,055 to €39,902
- Staff costs +€20,552
up €20,552 (+13.0%), from €157,876 to €178,428
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,079,733 | €2,118,610 | +€38,877 | +1.9% |
| Fixed assets | 21/28 | €1,872,573 | €1,903,176 | +€30,603 | +1.6% |
| Tangible fixed assets | 22/27 | €1,471 | €32,074 | +€30,603 | +2,080% |
| Furniture and vehicles | 24 | €1,471 | €32,074 | +€30,603 | +2,080% |
| Financial fixed assets | 28 | €1,871,102 | €1,871,102 | = | 0.0% |
| Current assets | 29/58 | €207,160 | €215,434 | +€8,274 | +4.0% |
| Amounts receivable within one year | 40/41 | €178,785 | €194,887 | +€16,102 | +9.0% |
| Other amounts receivable | 41 | €178,785 | €194,887 | +€16,102 | +9.0% |
| Cash at bank and in hand | 54/58 | €26,672 | €16,603 | -€10,069 | -37.8% |
| Deferred charges and accrued income | 490/1 | €1,703 | €3,945 | +€2,241 | +132% |
| Total equity and liabilities | 10/49 | €2,079,733 | €2,118,610 | +€38,877 | +1.9% |
| Equity | 10/15 | €672,318 | €339,555 | -€332,763 | -49.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €653,718 | €320,955 | -€332,763 | -50.9% |
| Distributable reserves | 133 | €653,718 | €320,955 | -€332,763 | -50.9% |
| Amounts payable | 17/49 | €1,407,416 | €1,779,056 | +€371,640 | +26.4% |
| Amounts payable after more than one year | 17 | €567,903 | €470,741 | -€97,162 | -17.1% |
| Financial debts | 170/4 | €567,903 | €470,741 | -€97,162 | -17.1% |
| Amounts payable within one year | 42/48 | €833,287 | €1,274,925 | +€441,637 | +53.0% |
| Current portion of amounts payable after more than one year | 42 | €101,214 | €117,759 | +€16,545 | +16.3% |
| Financial debts | 43 | €22,857 | €33,099 | +€10,242 | +44.8% |
| Credit institutions | 430/8 | €22,857 | €33,099 | +€10,242 | +44.8% |
| Trade debts | 44 | €11,109 | €22,956 | +€11,847 | +107% |
| Suppliers | 440/4 | €11,109 | €22,956 | +€11,847 | +107% |
| Taxes, remuneration and social security | 45 | €20,761 | €60,809 | +€40,048 | +193% |
| Taxes | 450/3 | €266 | €37,023 | +€36,757 | +13,818% |
| Remuneration and social security | 454/9 | €20,495 | €23,786 | +€3,291 | +16.1% |
| Other amounts payable | 47/48 | €677,346 | €1,040,302 | +€362,955 | +53.6% |
| Accrued charges and deferred income | 492/3 | €6,226 | €33,390 | +€27,164 | +436% |
| Remuneration, social security and pensions | 62 | €157,876 | €178,428 | +€20,552 | +13.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,522 | €3,643 | -€879 | -19.4% |
| Other operating charges | 640/8 | €1,416 | €1,288 | -€128 | -9.1% |
| Gross operating margin | 9900 | €268,154 | €190,635 | -€77,519 | -28.9% |
| Operating profit (loss) | 9901 | €104,340 | €7,276 | -€97,064 | -93.0% |
| Financial income | 75/76B | €48 | €58 | +€9 | +19.7% |
| Recurring financial income | 75 | €48 | €58 | +€9 | +19.7% |
| Financial charges | 65/66B | €15,055 | €39,902 | +€24,847 | +165% |
| Recurring financial charges | 65 | €15,055 | €39,902 | +€24,847 | +165% |
| Profit (loss) for the period before taxes | 9903 | €89,333 | -€32,568 | -€121,901 | |
| Income taxes | 67/77 | €25,123 | €195 | -€24,928 | -99.2% |
| Profit (loss) for the period | 9904 | €64,211 | -€32,763 | -€96,973 | |
| Profit (loss) for the period to be appropriated | 9905 | €64,211 | -€32,763 | -€96,973 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.